Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)
OTHER OTC:SHPHF
Holding SHPHF?
Track your performance easily
SHPHF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.11
Previous CloseN/A
Volume15.00
Average Volume (3M)1.00
Market Cap
$682.89M
Enterprise Value$1.47B
Total Cash (Recent Filing)$4.12B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.18
Next Earnings
Apr 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.46%
Share Statistics
EPS (TTM)0.00
Shares Outstanding9,329,999,000
10 Day Avg. Volume0
30 Day Avg. Volume1
Standard Deviation0.47
R-Squared0.05
Alpha0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.15
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap2.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.60
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sihuan Pharmaceutical Holdings Group News
PremiumCompany Announcements
Sihuan Pharmaceutical Updates on Xuanzhu Biopharm Share Transfer
PremiumCompany Announcements
Sihuan Pharma to Spin Off Xuanzhu Biopharm
PremiumCompany Announcements
Sihuan Pharma Subsidiaries Partner on Weight Loss DrugPremiumCompany Announcements
Sihuan Pharma to Spin Off Xuanzhu Biopharm
PremiumCompany Announcements
Sihuan Pharmaceutical Announces Share Buyback Plan
PremiumCompany Announcements
Sihuan Pharma Renews Key Contract with Hugel
PremiumCompany Announcements
Sihuan Pharmaceutical Reveals Mixed Half-Year Results
PremiumCompany Announcements
Sihuan Pharma Declares Mid-Year Cash DividendOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.71% Mutual Funds
<0.01% Other Institutional Investors
96.46% Public Companies and
Individual Investors
SHPHF FAQ
What was Sihuan Pharmaceutical Holdings Group Ltd.’s price range in the past 12 months?
Sihuan Pharmaceutical Holdings Group Ltd. lowest stock price was $0.03 and its highest was $0.11 in the past 12 months.
What is Sihuan Pharmaceutical Holdings Group Ltd.’s market cap?
Sihuan Pharmaceutical Holdings Group Ltd.’s market cap is $682.89M.
When is Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date?
Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date is Apr 01, 2025 which is in 60 days.
How were Sihuan Pharmaceutical Holdings Group Ltd.’s earnings last quarter?
Sihuan Pharmaceutical Holdings Group Ltd. released its earnings results on Aug 30, 2024. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
Is Sihuan Pharmaceutical Holdings Group Ltd. overvalued?
According to Wall Street analysts Sihuan Pharmaceutical Holdings Group Ltd.’s price is currently Overvalued.
Does Sihuan Pharmaceutical Holdings Group Ltd. pay dividends?
Sihuan Pharmaceutical Holdings Group Ltd. does not currently pay dividends.
What is Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate?
Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sihuan Pharmaceutical Holdings Group Ltd. have?
Sihuan Pharmaceutical Holdings Group Ltd. has 9,329,999,000 shares outstanding.
What happened to Sihuan Pharmaceutical Holdings Group Ltd.’s price movement after its last earnings report?
Sihuan Pharmaceutical Holdings Group Ltd. reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sihuan Pharmaceutical Holdings Group Ltd.?
Currently, no hedge funds are holding shares in SHPHF
---
Company Description
Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It focuses on the field of cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
---
Technical Analysis
Sino Biopharmaceutical
―
CSPC Pharmaceutical Group
―
China Medical System Holdings
―
Livzon Pharmaceutical Group
―
China Resources Pharmaceutical Group Ltd.
―
---